These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 20734088)

  • 41. [Nephropathic cystinosis: report of 2 cases and review of the literature].
    Knoepfelmacher M; Rocha R; Salgado LR; Semer M; Voss D; Wajchenberg BL; Liberman B
    Rev Assoc Med Bras (1992); 1994; 40(1):43-6. PubMed ID: 8061694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pathogenesis of cystinosis: mechanisms beyond cystine accumulation.
    Wilmer MJ; Emma F; Levtchenko EN
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F905-16. PubMed ID: 20826575
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis.
    Nießl C; Boulesteix AL; Oh J; Palm K; Schlingmann P; Wygoda S; Haffner D; Wühl E; Tönshoff B; Buescher A; Billing H; Hoppe B; Zirngibl M; Kettwig M; Moeller K; Acham-Roschitz B; Arbeiter K; Bald M; Benz M; Galiano M; John-Kroegel U; Klaus G; Marx-Berger D; Moser K; Mueller D; Patzer L; Pohl M; Seitz B; Treikauskas U; von Vigier RO; Gahl WA; Hohenfellner K
    Mol Genet Metab; 2022 Aug; 136(4):268-273. PubMed ID: 35835062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis.
    van Stein C; Klank S; Grüneberg M; Ottolenghi C; Grebe J; Reunert J; Harms E; Marquardt T
    Orphanet J Rare Dis; 2021 Sep; 16(1):387. PubMed ID: 34521447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cysteamine in the treatment of cystinosis in children. In vitro and in vivo studies].
    Louis JJ; Guibaud P; Dumoulin R; Parchoux B; Zabot MT; Bureau J; Baltassat P; Frederich A; Larbre F
    Pediatrie; 1984 Dec; 39(8):619-33. PubMed ID: 6535971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human and animal fertility studies in cystinosis reveal signs of obstructive azoospermia, an altered blood-testis barrier and a subtherapeutic effect of cysteamine in testis.
    Reda A; Veys K; Kadam P; Taranta A; Rega LR; Goffredo BM; Camps C; Besouw M; Cyr D; Albersen M; Spiessens C; de Wever L; Hamer R; Janssen MCH; D'Hauwers K; Wetzels A; Monnens L; van den Heuvel L; Goossens E; Levtchenko E
    J Inherit Metab Dis; 2021 Nov; 44(6):1393-1408. PubMed ID: 34494673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bone Disease in Nephropathic Cystinosis: Beyond Renal Osteodystrophy.
    Machuca-Gayet I; Quinaux T; Bertholet-Thomas A; Gaillard S; Claramunt-Taberner D; Acquaviva-Bourdain C; Bacchetta J
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32354056
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multinucleated podocytes as a clue to diagnosis of juvenile nephropathic cystinosis.
    Ogata A; Deki S; Uchimura T; Inaba A; Otani M; Ito S
    Pediatr Nephrol; 2024 Feb; 39(2):609-612. PubMed ID: 37572116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cystinosin is a Component of the Vacuolar H+-ATPase-Ragulator-Rag Complex Controlling Mammalian Target of Rapamycin Complex 1 Signaling.
    Andrzejewska Z; Nevo N; Thomas L; Chhuon C; Bailleux A; Chauvet V; Courtoy PJ; Chol M; Guerrera IC; Antignac C
    J Am Soc Nephrol; 2016 Jun; 27(6):1678-88. PubMed ID: 26449607
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of cystinosis with cysteamine. A pilot study determining dose and form of application.
    Bergonzi E; Herren A; Lavanchy P; Bühlmann C; Wyss SR; Lüthy C; Oetliker O
    Helv Paediatr Acta; 1981 Nov; 36(5):437-43. PubMed ID: 7031022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of cystinosis using cysteamine].
    Broyer M; Tete MJ
    Ann Pediatr (Paris); 1990 Feb; 37(2):91-3. PubMed ID: 2321906
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosis.
    Levtchenko EN; van Dael CM; de Graaf-Hess AC; Wilmer MJ; van den Heuvel LP; Monnens LA; Blom HJ
    Pediatr Nephrol; 2006 Jan; 21(1):110-3. PubMed ID: 16252107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved renal function in children with cystinosis treated with cysteamine.
    Markello TC; Bernardini IM; Gahl WA
    N Engl J Med; 1993 Apr; 328(16):1157-62. PubMed ID: 8455682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Worldwide disparities in access to treatment and investigations for nephropathic cystinosis: a 2023 perspective.
    Regnier M; Flammier S; Boutaba M; Ndongo AA; Servais A; Schaefer F; Levtchenko E; Bacchetta J; Bertholet-Thomas A
    Pediatr Nephrol; 2024 Apr; 39(4):1113-1123. PubMed ID: 37978055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cysteamine therapy for children with nephropathic cystinosis.
    Gahl WA; Reed GF; Thoene JG; Schulman JD; Rizzo WB; Jonas AJ; Denman DW; Schlesselman JJ; Corden BJ; Schneider JA
    N Engl J Med; 1987 Apr; 316(16):971-7. PubMed ID: 3550461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cysteamine-bicalutamide combination therapy corrects proximal tubule phenotype in cystinosis.
    Jamalpoor A; van Gelder CA; Yousef Yengej FA; Zaal EA; Berlingerio SP; Veys KR; Pou Casellas C; Voskuil K; Essa K; Ammerlaan CM; Rega LR; van der Welle RE; Lilien MR; Rookmaaker MB; Clevers H; Klumperman J; Levtchenko E; Berkers CR; Verhaar MC; Altelaar M; Masereeuw R; Janssen MJ
    EMBO Mol Med; 2021 Jul; 13(7):e13067. PubMed ID: 34165243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Follow-up and treatment of adults with cystinosis in the Netherlands.
    Geelen JM; Monnens LA; Levtchenko EN
    Nephrol Dial Transplant; 2002 Oct; 17(10):1766-70. PubMed ID: 12270982
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives.
    Cherqui S; Courtoy PJ
    Nat Rev Nephrol; 2017 Feb; 13(2):115-131. PubMed ID: 27990015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis.
    Iwata F; Kuehl EM; Reed GF; McCain LM; Gahl WA; Kaiser-Kupfer MI
    Mol Genet Metab; 1998 Aug; 64(4):237-42. PubMed ID: 9758713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergistic Cysteamine Delivery Nanowafer as an Efficacious Treatment Modality for Corneal Cystinosis.
    Marcano DC; Shin CS; Lee B; Isenhart LC; Liu X; Li F; Jester JV; Pflugfelder SC; Simpson J; Acharya G
    Mol Pharm; 2016 Oct; 13(10):3468-3477. PubMed ID: 27571217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.